Suppr超能文献

血小板成分中细菌生长特性的荟萃分析:完善模拟分析的输入参数,以比较不同检测策略的相对安全性。

Meta-analysis of bacterial growth characteristics in platelet components: Refining the inputs of a simulation analysis comparing the relative safety of testing strategies.

机构信息

ARUP Laboratories, Salt Lake City, Utah, USA.

Department of Pathology, University of Utah, Salt Lake City, Utah, USA.

出版信息

Transfusion. 2023 Sep;63(9):1719-1727. doi: 10.1111/trf.17497. Epub 2023 Aug 17.

Abstract

BACKGROUND

The relative safety of bacterial risk control strategies for platelets that include culture with or without rapid testing has been compared using simulation analysis. A wide range of bacterial lag and doubling times were included. However, published data on growth rates are available and these data have not been synthesized. We conducted a systematic review and meta-analysis to estimate growth rates and used these estimates to refine a comparative safety analysis of bacterial risk control strategies in the FDA guidance STUDY DESIGN AND METHODS: Data were extracted from published studies on bacterial growth rates in platelet components during storage. These data were used to estimate the practical range of growth rates. This refined the inputs for a simulation model comparing the safety of the testing strategies.

RESULTS

In total, 108 growth curves for 11 different aerobic organisms were obtained. Doubling times ranged from 0.8 to 12 h, but the lower 90% range was approximately 1-5 h. The revised comparative safety simulation using the narrower 1-5-h range showed similar rankings to the prior simulation, with 48-h large-volume delayed sampling with 7-day expiration (48C-7) demonstrating the lowest-ranking relative performance at the 10 and 10 colony forming unit (CFU)/mL exposure thresholds.

DISCUSSION

This was a two-step study. First, meta-analysis of published data on aerobic bacterial growth rates in stored platelets showed the vast majority of doubling times were 1-5 h. Next, an updated comparative safety simulation yielded similar results to a prior study, with 48C-7 showing the least favorable relative safety performance.

摘要

背景

通过模拟分析比较了包括培养和/或快速检测在内的血小板细菌风险控制策略的相对安全性。研究纳入了广泛的细菌潜伏期和倍增时间。然而,目前已有关于细菌增长率的发表数据,且尚未对这些数据进行综合分析。我们进行了一项系统评价和荟萃分析,以评估增长率,并利用这些估计值来改进 FDA 指南中血小板细菌风险控制策略的比较安全性分析。

研究设计和方法

从血小板成分储存期间细菌生长率的已发表研究中提取数据。这些数据用于估计实际增长率范围。这对比较测试策略安全性的模拟模型的输入进行了优化。

结果

共获得 11 种需氧菌的 108 个生长曲线。倍增时间范围为 0.8-12 小时,但 90%下限约为 1-5 小时。使用更窄的 1-5 小时范围进行的修正后相对安全性模拟与之前的模拟具有相似的排名,48 小时大体积延迟采样加 7 天有效期(48C-7)在 10 和 10 菌落形成单位(CFU)/mL 暴露阈值下显示出相对性能最差。

讨论

这是一项两步研究。首先,对已发表的储存血小板中需氧菌增长率数据进行荟萃分析,结果表明大多数倍增时间为 1-5 小时。其次,更新的相对安全性模拟结果与之前的研究相似,48C-7 显示出相对安全性最差。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验